DeniLA: Comprehensive Demographics and Clinical Profile of NSCLC Patients: Analyzing Guideline-Concordant Care in First-line Treatment Patterns

Not yet recruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

July 31, 2025

Primary Completion Date

April 30, 2027

Study Completion Date

April 30, 2027

Conditions
Lung Neoplasms
Trial Locations (6)

Unknown

Ensino e Terapia de Inovação Clinica AMO- ETICA, Salvador

Instituto D'oR de Pesquisa e Ensino, Salvador

Instituto D'oR de Pesquisa e Ensino, Recife

Oncoclínicas Rio de Janeiro S.A, Rio de Janeiro

Fundação Antonio Prudente, São Paulo

Instituto D'Or de Pesquisa e Ensino, São Paulo

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY